Dr. Thomas Klein is a board-certified clinical hematologist serving as Chief Medical Officer at Kantesti AI. With over 15 years of experience in laboratory medicine and a strong interest in AI-supported interpretation of blood test results, he works to connect new technology with everyday clinical practice. His areas of interest include biomarker analysis, clinical decision support research and population-specific reference range optimization. As CMO, he contributes clinical input to the platform's internal benchmarking and provides clinical oversight for the medical quality of Kantesti's educational reports.

Dibucaine Number Test: What Low Results Mean for Surgery

Категории
Articles

Anesthesia Safety Lab Interpretation 2026 Update Patient-Friendly A low dibucaine number can suggest an inherited enzyme variant that prolongs paralysis after succinylcholine or mivacurium. Tell your anesthesiologist before treatment; the result measures enzyme behavior, not how much enzyme activity you have. 📖 ~12 minutes 📅 October 9, 2026 📝 Published: October 9, 2026 🩺 Medically […]

Sweat Chloride Test Results: Borderline and Next Steps

Категории
Articles

Cystic Fibrosis Lab Interpretation 2026 Update Patient-Friendly A borderline sweat chloride result of 30–59 mmol/L does not confirm cystic fibrosis. It means the result needs follow-up: usually repeat testing at an experienced center, review of symptoms and newborn screening, and sometimes CFTR genetic or functional evaluation. 📖 ~12 minutes 📅 October 8, 2026 📝 Published: […]

Digoxin Level: Safe Targets, Sample Timing and Toxicity

Категории
Articles

Medication Safety Lab Interpretation 2026 Update Patient-Friendly For heart failure, digoxin levels are usually targeted around 0.5–0.9 ng/mL; for atrial fibrillation, current US guidance recommends below 1.2 ng/mL when levels are measured. Samples generally need at least 6–8 hours after a dose. Toxicity can occur within the laboratory interval, especially with kidney impairment, low potassium […]

Lamotrigine Therapeutic Range: Levels and Toxicity Signs

Категории
Articles

Medication Monitoring Lab Interpretation 2026 Update Patient-Friendly For epilepsy, many laboratories use 3–15 mg/L as a reference interval; bipolar disorder has no established concentration target. Interpret the result alongside dose timing, symptoms, and interacting medicines—not as an instruction to change your dose. 📖 ~12 minutes 📅 October 8, 2026 📝 Published: October 8, 2026 🩺 […]

GAD65 Antibody Positive: Diabetes vs Neurologic Clues

Категории
Articles

Autoimmune Diabetes Lab Interpretation 2026 Update Patient-Friendly A positive result can support pancreatic autoimmunity, help investigate a specific neurologic syndrome, or be incidental. The deciding clues are the clinical picture, laboratory method, units, and supporting tests—not the positive flag alone. 📖 ~12 minutes 📅 October 8, 2026 📝 Published: October 8, 2026 🩺 Medically Reviewed: […]

ADAMTS13 Activity: Low Results, TTP Risk and Next Steps

Категории
Articles

Hematology Lab Interpretation 2026 Update Patient-Friendly ADAMTS13 activity below 10% strongly supports TTP when low platelets and red-cell destruction occur together, but an isolated result does not prove an acute episode. Suspected TTP needs emergency assessment and treatment decisions without waiting for the laboratory result. 📖 ~12 minutes 📅 October 8, 2026 📝 Published: October […]

DPYD Testing Before Chemotherapy: Understanding Results

Категории
Articles

Chemotherapy Safety Lab Interpretation 2026 Update Patient-Friendly DPYD testing identifies inherited variants that can make fluorouracil or capecitabine dangerously difficult to clear. Results help clinicians choose treatment and starting doses, but a negative genetic screen does not guarantee safety. 📖 ~12 minutes 📅 October 7, 2026 📝 Published: October 7, 2026 🩺 Medically Reviewed: October […]

Carbamazepine Level: Trough Timing, Range and Toxicity

Категории
Articles

Medication Monitoring Lab Interpretation 2026 Update Patient-Friendly A result inside the laboratory range is not a safety certificate. The last dose, recent treatment changes and accompanying symptoms can completely change its meaning. 📖 ~12 minutes 📅 October 7, 2026 📝 Published: October 7, 2026 🩺 Medically Reviewed: October 7, 2026 ✅ Evidence-Based This guide was […]

Tacrolimus Trough Level: Dose Timing, Targets and Toxicity

Категории
Articles

Transplant Medication Safety Lab Interpretation 2026 Update Patient-Friendly A tacrolimus trough level measures the drug in whole blood immediately before your next scheduled dose—usually 12 hours after twice-daily treatment or 24 hours after once-daily treatment. Targets depend on your formulation, transplanted organ and time since transplant; mistimed samples can mislead, and dose changes must come […]

Cat Scratch Disease Test: How to Read Bartonella Titers

Категории
Articles

Infectious Diseases Lab Interpretation 2026 Update Patient-Friendly A swollen lymph node and a positive Bartonella antibody result can fit cat scratch disease—but neither establishes the diagnosis alone. Timing, the laboratory method, and the specimen chosen for PCR can change the next step. 📖 ~12 minutes 📅 October 7, 2026 📝 Published: October 7, 2026 🩺 […]